In annis, et scale de pharmaceutical distribution industria est constanter auctus, et non est a significant demanda ad terminalis distribution, quae promoveatur automation et intelligens progressionem et logistics in pharmaceutical distribution.
1.Enterprise introduction
Guangzhou pharmaceutical Co., Ltd. erat statutum in MCMLI cum registered caput 2.227 billion Yuan. Est maximae sino aliena iuncturam venture pharmaceutical distribution Enterprise in Sinis. Guangzhou Pharmaceutical has a landmark brand that has been operating in the wholesale and retail fields of pharmaceuticals for nearly 70 years, with over 50000 product specifications in pharmaceuticals, medical devices, health products, and other fields. Etiam praebet valorem-additae officia in pharmaceutical supplementum catenam, ut tertius-pars pharmaceutical logistics et hospitalis pharmacy integration servicia. Et res perficientur semper praeferebantur in summo quinque in eodem industria in Sinis.
2.Project Exemplum
- Quattuor major automated CELLA storage centers
- In Inventarium CELLA
- latus legendo CELLA,
- Online legendo CELLA
- 0-40 ℃ & 2-8 ℃
- sicut / Rs et related supporting systems
- frigus repono eligeremus apparatu systems
- Sorting et Porting Systems et Alia Systems
- XXI sets of track cuniculum type tinnulae greges systems
- (XXVI) bins et pallets
Robotech est creatusQuattuor major automated CELLA repono centerssecundum rationem medicamento qualitas signa. Inter eosEt elevatum Inventarium CELLA, latus legendo CELLA et online legendo CELLAset quod constant temperatus horreis et operantes amet temperatus est0-40 ℃ANTOLIUM; Refrigerated elevatur CELLA est ut humilis temperatus CELLA, cum operantes amet temperatus2-8 ℃.
TotumAutomated CELLAincludesSicut / RS Et related supporting systems, frigus repono legendo apparatu systems, genus et importans systems,et aliis systems. Inter eosUt / RS SystemsDe quatuor major warehousing et repono centers omnes provisum est a Robotech Automation Technology (Suzhou) Co., Ltd. (Hereinafter ad quod Robotech), cum summaXXI sets of track cuniculum typeStacker Cicero Systemscogitavit, comprehendo plus quam(XXVI) bins et grabatis.
3.Project advantages
Post completionem de project, cum incremento in logistics volumine, numerus CELLA operatorsMinuatur ab L%, In annua throughput facultatemXXIV million boxeset cotidiana ordine processui capacitatem(CCXX) ordinem lineae, unde in a significant breakthrough in opere efficientiam. Non solum autem facti unum ex modern pharmaceutical logistics distribution hubs cum summo automation, fortissimum intelligentia, et latissime technological application in regionem, sed etiam erit etiam suscipere negotium progressionem Guangzhou pharmaceutical Co., Ltd in altera X annis,Achieving logistics ministerium requisitis princeps automation, princeps intelligentia et altum efficientiam in pharmaceutical supplementum catenae ..
4.Project Quisque ornare ipsum
Ex ingens numerus Skus et excelsum throughput characteres in pharmaceutical distribution industria, robotech elegit estNigrum Panther Et sicut / Rs Systemhuius project. Haec seriesDuplex columna stacker gruesAlia exempla ut unum altitudinem et multiple profundum et propria celeritate flexibilitate et reliability. Est idoneam ad grabatum storage systems cum onus capacitatem minus quam1500kgacaltitudo 25m. Operating celeritas fabrica potest pervenire240M / minEt cum acceleratione0.6m / S2.
In responsione ad requisita de automated CELLA project, robotech ulterius customized in project fundatur in lectio arbitrium. Adopto servo coegi imperium, in positioning accurate, responsio celeritate et tractantem efficientiam valde superior vexillum exemplar. Insuper et servo coegi etiam habet bonum anti munus, faciens operationem in tanquam gruma leviore,cum significantly melius salus et stabilitatem.
Nanjing certiorem repono apparatu (Group) Co., Ltd
Mobile Phone: +8613636391926 / LXXXVI 13851666948
Oratio: No. CDLXX, Yinhua Street, Jiangning District, Nanjing CTIY, Sinis (CCXI) CII
Website:www.informack.com
Email:[Email protected]
[Email protected]
Post tempus: Mar-22-2024
